Geographic Variation in the Treatment of U.S. Adult Heart Transplant Candidates

Journal of the American College of Cardiology

Volumn 71, Issue 16, 2018, Pages 1715-1725

  Parker, William F ^a,b   Anderson, Allen S ^c   Hedeker, Donald ^a   Huang, Elbert S ^a,b   Garrity, Edward R ^a,b   Siegler, Mark ^a,b   Churpek, Matthew M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Northwestern University Feinberg School of Medicine   (United States)

Author keywords

ethics; heart transplantation; organ allocation

Indexed keywords

INOTROPIC AGENT;

ADULT; ARTICLE; CARDIOGENIC SHOCK; DRUG MEGADOSE; FEMALE; GEOGRAPHICAL VARIATION (SPECIES); GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MIDDLE AGED; STANDARDIZATION; UNITED STATES;

EID: 85044118163     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2018.02.030     Document Type: Article

References (33)

1. Benjamin, E.J., Blaha, M.J., Chiuve, S.E., et al., for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation 135 (2017), e146–e603.
2. Colvin, M., Smith, J.M., Skeans, M.A., et al. OPTN/SRTR 2015 Annual Data Report: Heart. Am J Transplant 17 Suppl 1 (2017), 286–356.
3. U.S. Department of Health and Human Services. Organ Procurement and Transplantation Network: National Data. Available at: https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/#. Accessed June 27, 2017.
4. OPTN. Policy 6: Allocation of Hearts and Heart-Lungs. In Organ Procurement and Transplant Network: Policies. Available at: https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf#nameddest=Policy_06. Accessed December 10, 2016.
5. Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). Organ procurement and transplantation network: final rule. Fed Regist 78 (2013), 40033–40042.
6. Movsesian M. Should Doctors Game the Transplant Wait List To Help Their Patients? NPR website. July 24, 2016. Available at: http://www.npr.org/sections/health-shots/2016/07/24/486787474/should-doctors-game-the-transplant-wait-list-to-help-their-patients. Accessed September 27, 2016.
7. Stevenson, L.W., The urgent priority for transplantation is to trim the waiting list. J Heart Lung Transplant 32 (2013), 861–867.
8. Scanlon, D.P., Hollenbeak, C.S., Lee, W., Loh, E., Ubel, P.A., Does competition for transplantable hearts encourage ‘gaming’ of the waiting list?. Health Aff (Millwood) 23 (2004), 191–198.
9. U.S. Department of Health and Human Services. Organ Procurement and Transplantation Network: Modify Adult Heart Allocation 2016 2nd Round. Available at: https://optn.transplant.hrsa.gov/governance/public-comment/modify-adult-heart-allocation-2016-2nd-round/. Accessed December 15, 2016.
10. Reynolds, H.R., Hochman, J.S., Cardiogenic shock: current concepts and improving outcomes. Circulation 117 (2008), 686–697.
11. Parker, W.F., Garrity, E.R., Fedson, S., Churpek, M.M., Potential impact of a shock requirement on adult heart allocation. J Heart Lung Transplant 36 (2017), 1013–1016.
12. Parker, W.F., Garrity, E.R., Fedson, S., Churpek, M.M., Trends in the use of inotropes to list adult heart transplant candidates at status 1A. Circ Heart Fail, 10, 2017, e004483.
13. Hatch O. S.2048—National Organ Transplant Act. 98th Congress (1983–1984). October 19, 1984. Available at: https://www.congress.gov/bill/98th-congress/senate-bill/2048. Accessed December 23, 2015.
14. Johnson, M.J., Bland, J.M., Davidson, P.M., Newton, P.J., Oxberry, S.G., Abernethy, A.P., Currow, D.C., The relationship between two performance scales: New York Heart Association Classification and Karnofsky Performance Status Scale. J Pain Symptom Manage 47 (2014), 652–658.
15. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949:191–205.
16. Hirschman, A.O., National Power and the Structure of Foreign Trade. 1945, University of California Press, Berkeley, CA.
17. Hedeker, D., Multilevel models for ordinal and nominal variables. de Leeuw, J., Meijer, E., (eds.) Handbook of Multilevel Analysis, 2008, Springer, New York, NY, 237–274 Available at: https://link.springer.com/chapter/10.1007/978-0-387-73186-5_6 Accessed July 28, 2017.
18. Snijders, T., Bosker, R., Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. 2nd edition, 2011, SAGE Publications, Los Angeles, CA.
19. Krumholz, H.M., Wang, Y., Mattera, J.A., et al. An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation 113 (2006), 1693–1701.
20. Asch, D.A., Nicholson, S., Srinivas, S., Herrin, J., Epstein, A.J., Evaluating obstetrical residency programs using patient outcomes. JAMA 302 (2009), 1277–1283.
21. Krumholz, H.M., Lin, Z., Keenan, P.S., et al. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA 309 (2013), 587–593.
22. Shahian, D.M., Torchiana, D.F., Shemin, R.J., Rawn, J.D., Normand, S.-L.T., Massachusetts cardiac surgery report card: implications of statistical methodology. Ann Thorac Surg 80 (2005), 2106–2113.
23. Shahian, D.M., Normand, S.-L.T., Comparison of “risk-adjusted” hospital outcomes. Circulation 117 (2008), 1955–1963.
24. Austin, P.C., Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28 (2009), 3083–3107.
25. Wiesner, R., Edwards, E., Freeman, R., et al., for the United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124 (2003), 91–96.
26. Snyder, J., Gaming the liver transplant market. J Law Econ Organ 26 (2010), 546–568.
27. Cohn, J.N., Goldstein, S.O., Greenberg, B.H., et al., for the Vesnarinone Trial Investigators. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. N Engl J Med 339 (1998), 1810–1816.
28. Packer, M., Carver, J.R., Rodeheffer, R.J., et al., for the PROMISE Study Research Group. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 325 (1991), 1468–1475.
29. Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62 (2013), e147–e239.
30. Singh, T.P., Milliren, C.E., Almond, C.S., Graham, D., Survival benefit from transplantation in patients listed for heart transplantation in the United States. J Am Coll Cardiol 63 (2014), 1169–1178.
31. Uccellini K, OPTN/UNOS Thoracic Organ Transplantation Committee. Proposal to Modify the Adult Heart Allocation System. Briefing paper. 2016. Available at: https://optn.transplant.hrsa.gov/media/2006/thoracic_brief_201612.pdf. Accessed March 12, 2016.
32. Narang, N., Thibodeau, J.T., Levine, B.D., et al. Inaccuracy of estimated resting oxygen uptake in the clinical setting. Circulation 129 (2014), 203–210.
33. Balik, M., Pachl, J., Hendl, J., Martin, B., Jan, P., Jan, H., Effect of the degree of tricuspid regurgitation on cardiac output measurements by thermodilution. Intensive Care Med 28 (2002), 1117–1121.